Cel AI (LSE:CLAI) EBIT per Share : £-0.00 (TTM As of Feb. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Cel AI EBIT per Share?

Cel AI's EBIT per Share for the six months ended in Feb. 2024 was £-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 was £-0.00.

During the past 3 years, the average EBIT per Share Growth Rate was -81.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Cel AI's EBIT per Share or its related term are showing as below:

LSE:CLAI' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -81.7 Med: -81.7 Max: -81.7
Current: -81.7

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Cel AI was -81.70% per year. The lowest was -81.70% per year. And the median was -81.70% per year.

LSE:CLAI's 3-Year EBIT Growth Rate is ranked worse than
98.08% of 1507 companies
in the Consumer Packaged Goods industry
Industry Median: 5.9 vs LSE:CLAI: -81.70

Cel AI's EBIT for the six months ended in Feb. 2024 was £-0.62 Mil.

Cel AI EBIT per Share Historical Data

The historical data trend for Cel AI's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cel AI EBIT per Share Chart

Cel AI Annual Data

Trend

Aug19

Aug20

Aug21

Aug22

Aug23

EBIT per Share

-0.01

Cel AI Semi-Annual Data
	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
EBIT per Share	Get a 7-Day Free Trial					-0.01	-0.01	-	-	-

Cel AI EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Cel AI's EBIT per Share for the fiscal year that ended in Aug. 2023 is calculated as

	EBIT per Share		(A: Aug. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.334	/	537.962
=	-0.01

Cel AI's EBIT per Share for the quarter that ended in Feb. 2024 is calculated as

	EBIT per Share		(Q: Feb. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.617	/	537.962
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.00

Cel AI (LSE:CLAI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Cel AI EBIT per Share Related Terms

Thank you for viewing the detailed overview of Cel AI's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cel AI (LSE:CLAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cel AI PLC (LSE:CLAI) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

6XS:Germany

Address

16 Great Queen Street, 9th Floor, London, GBR, WC2B 5DG

Website

https://www.cellular-goods.com

Cellular Goods PLC develops efficacy-led and research-backed cannabinoid products. The company is launching with two product brands covering distinct market segments: a face-mask and serum-containing synthetic CBD, and a topical athletic recovery gel roll-on product. These will be made available through partnerships with online and physical retailers and direct to consumers through the company's website.

Cel AI (LSE:CLAI) Headlines

No Headlines